Delirium

Delirium is an acute, fluctuating disturbance of consciousness and cognition caused by an underlying medical condition, affecting up to 30% of hospitalised older adults and associated with increased mortality.

Key Facts

Delirium affects up to 30% of hospitalised older adults and 50-80% of ICU patients 4AT is the recommended rapid screening tool (NICE NG103, Sign 157); score ≥4 suggests delirium Three subtypes: hyperactive (agitation), hypoactive (most common, worst prognosis, often missed), mixed Always reversible in principle — identify and treat the underlying cause; use the mnemonic PINCH ME (Pain, Infection, Nutrition, Constipation, Hydration, Medication, Environment) Avoid antipsychotics unless patient is at risk of harm; if essential, use haloperidol 0.5-1mg (avoid in Lewy body/Parkinson's — use lorazepam 0.5-1mg) Predisposing factors: age >65, dementia, severe illness, hip fracture, visual/hearing impairment Precipitating factors: infection (UTI, pneumonia), drugs (opioids, anticholinergics, benzodiazepines), pain, constipation, urinary retention, metabolic disturbance Delirium is associated with increased mortality (30-40% at 1 year), prolonged hospital stay, and accelerated cognitive decline

Overview

Key Facts

Delirium is a medical emergency requiring urgent identification and treatment of the underlying cause. Prevention is more effective than treatment.

Epidemiology

  • Affects 20-30% of medical inpatients >65; up to 50% post-operatively
  • Hypoactive delirium accounts for 50-70% and is frequently unrecognised
  • Incidence increases with age, frailty, and cognitive impairment

Aetiology

PINCH ME mnemonic:

  • Pain
  • Infection (UTI, pneumonia, cellulitis)
  • Nutrition (dehydration, electrolyte disturbance)
  • Constipation / urinary retention
  • Hydration (dehydration, fluid overload)
  • Medication (opioids, anticholinergics, benzodiazepines, steroids, drug/alcohol withdrawal)
  • Environment (unfamiliar surroundings, sleep deprivation, immobility)

Pathophysiology

  • Multifactorial model: predisposing vulnerability + precipitating insult
  • Neuroinflammation: systemic inflammation → microglial activation → neurotransmitter imbalance
  • Cholinergic deficiency and dopaminergic excess are central to the pathophysiology
  • Disruption of the ascending reticular activating system
  • Blood-brain barrier dysfunction during acute illness

Clinical Presentation

Core Features

  • Acute onset (hours to days)
  • Fluctuating course (lucid intervals)
  • Inattention (key feature — cannot sustain attention)
  • Altered level of consciousness
  • Cognitive disturbance (disorientation, memory impairment)
  • Perceptual disturbance (hallucinations, illusions)
  • Psychomotor disturbance (agitation or withdrawal)
  • Sleep-wake cycle disturbance

Subtypes

  • Hyperactive: agitation, restlessness, hallucinations, aggression (25%)
  • Hypoactive: withdrawal, drowsiness, reduced movement, quiet confusion (50-70%) — worst prognosis, often missed
  • Mixed: alternating between hyperactive and hypoactive (25%)

Red Flags

  • Sudden onset confusion in previously well/stable patient
  • New agitation or aggression in a patient with dementia
  • Reduced consciousness level (GCS drop)
  • Fever with confusion (sepsis)
  • Head injury with confusion (intracranial pathology)
  • Post-operative confusion (common; always investigate)

Differential Diagnosis

DiagnosisKey FeaturesInvestigation
DementiaChronic, gradual onset, no fluctuation in alertnessCognitive assessment, collateral history
DepressionLow mood, anhedonia, psychomotor retardationPHQ-9, psychiatric assessment
Psychosis (functional)Younger, clear sensorium, organised delusionsPsychiatric assessment
Non-convulsive status epilepticusSubtle motor signs, unexplained altered consciousnessEEG
StrokeFocal neurological deficit, sudden onsetCT head
HypoglycaemiaDiaphoresis, tremor, rapid response to glucoseCBG

Diagnosis / Investigation

Bedside

  • 4AT screening tool: ≥4 = probable delirium (alertness, AMT4, attention, acute change)
  • Observations: temperature, HR, BP, O2 sats, RR, blood glucose
  • Urinalysis (UTI)
  • ECG
  • Pain assessment
  • Medication chart review

Bloods

  • FBC, CRP (infection)
  • U&Es (dehydration, AKI, electrolyte disturbance)
  • LFTs, calcium, magnesium, phosphate
  • Blood glucose, HbA1c
  • TFTs
  • Blood cultures (if pyrexial)
  • B12, folate (if nutritional deficiency suspected)

Imaging

  • CXR (pneumonia)
  • CT head: if head injury, focal neurology, no clear cause identified, anticoagulated
  • CT abdomen/pelvis: if intra-abdominal cause suspected

Special Tests

  • MSU (urine culture)
  • Confusion Assessment Method (CAM): research gold standard
  • EEG: if non-convulsive status suspected (diffuse slowing in delirium)
  • Lumbar puncture: if meningitis/encephalitis suspected

Management

Non-pharmacological (FIRST LINE)

  • Identify and treat underlying cause (treat infection, stop offending drugs, correct dehydration, relieve pain/constipation/retention)
  • Reorientation: clocks, calendars, familiar objects, consistent staff
  • Ensure sensory aids (glasses, hearing aids)
  • Promote sleep-wake cycle: natural light, reduce nocturnal interventions
  • Mobilise early: avoid unnecessary catheterisation and restraint
  • Involve family/carers
  • Avoid unnecessary ward moves
  • Delirium prevention: NICE CG103 recommends multicomponent intervention for all at-risk patients

Pharmacological

  • Only if patient at risk of harm to self or others, and non-pharmacological measures have failed
  • Haloperidol 0.5mg PO/IM (start low, max 2mg/24h in elderly); avoid in Parkinson's/Lewy body dementia
  • Lorazepam 0.5-1mg PO/IM: preferred in Parkinson's/Lewy body, alcohol withdrawal, seizure risk
  • Olanzapine 2.5-5mg: alternative if haloperidol contraindicated
  • Review and stop offending medications: opioids, anticholinergics, benzodiazepines, steroids
  • Treat underlying causes: antibiotics for infection, IV fluids for dehydration, analgesia for pain

Surgical/Interventional

  • Address surgical causes: urinary retention (catheterise), constipation (enemas), fracture fixation

Referral Criteria

  • Persistent delirium (>2 weeks): consider psychiatric/geriatric review
  • Delirium superimposed on dementia: specialist assessment
  • Complex cases: liaison psychiatry

Prognosis

  • In-hospital mortality: 10-26% (2× higher than non-delirious patients)
  • 1-year mortality: 30-40% (delirium is an independent predictor of death)
  • Mean excess hospital stay: 7-10 days
  • 30-50% develop dementia within 2-3 years of a delirium episode
  • Full recovery in approximately 50%; persistent cognitive impairment in many
  • Hypoactive delirium has worst prognosis (often undiagnosed)
  • Prevention reduces delirium incidence by 30-40% (multicomponent interventions)

Other Relevant Information

4AT Rapid Clinical Test for Delirium

ItemScore
Alertness (normal = 0; abnormal = 4)0 or 4
AMT4 (age, DOB, place, year — all correct = 0; 1 error = 1; ≥2 errors or untestable = 2)0, 1, or 2
Attention (months backwards — 7+ correct = 0; <7 or refuses = 1; untestable = 2)0, 1, or 2
Acute change or fluctuating course (no = 0; yes = 4)0 or 4
Total ≥4: possible delirium ± cognitive impairment
Total 1-3: possible cognitive impairment
Total 0: delirium or cognitive impairment unlikely

PINCH ME — Causes of Delirium

LetterCause
PPain
IInfection
NNutrition
CConstipation
HHydration
MMedication
EEnvironment